June 17, 2013 in Health, Nation/World

Court: ’pay to delay’ generic drugs can be illegal

Associated Press
 

WASHINGTON — The Supreme Court says deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can sometimes be illegal.

The justices voted 5-3 to allow the government to challenge what it calls “pay-for-delay” deals or “reverse settlements.” That’s when big pharmaceutical corporations pay generic drug competitors to delay releasing their cheaper versions of brand-name drugs.

The Obama administration says these deals profit drug companies, but harm consumers by adding to drug costs. The pharmaceutical companies say they need to preserve revenue from patented products to recover development costs. And both the large companies and the generic makers say the marketing of generics often is hastened by these deals.

Justice Samuel Alito did not take part in the case.

© Copyright 2013 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


There are four comments on this story. Click here to view comments >>

Get stories like this in a free daily email